Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;73(5):691-705.
doi: 10.1111/j.1365-2125.2012.04167.x.

A new taxonomy for describing and defining adherence to medications

Affiliations

A new taxonomy for describing and defining adherence to medications

Bernard Vrijens et al. Br J Clin Pharmacol. 2012 May.

Abstract

Interest in patient adherence has increased in recent years, with a growing literature that shows the pervasiveness of poor adherence to appropriately prescribed medications. However, four decades of adherence research has not resulted in uniformity in the terminology used to describe deviations from prescribed therapies. The aim of this review was to propose a new taxonomy, in which adherence to medications is conceptualized, based on behavioural and pharmacological science, and which will support quantifiable parameters. A systematic literature review was performed using MEDLINE, EMBASE, CINAHL, the Cochrane Library and PsycINFO from database inception to 1 April 2009. The objective was to identify the different conceptual approaches to adherence research. Definitions were analyzed according to time and methodological perspectives. A taxonomic approach was subsequently derived, evaluated and discussed with international experts. More than 10 different terms describing medication-taking behaviour were identified through the literature review, often with differing meanings. The conceptual foundation for a new, transparent taxonomy relies on three elements, which make a clear distinction between processes that describe actions through established routines ('Adherence to medications', 'Management of adherence') and the discipline that studies those processes ('Adherence-related sciences'). 'Adherence to medications' is the process by which patients take their medication as prescribed, further divided into three quantifiable phases: 'Initiation', 'Implementation' and 'Discontinuation'. In response to the proliferation of ambiguous or unquantifiable terms in the literature on medication adherence, this research has resulted in a new conceptual foundation for a transparent taxonomy. The terms and definitions are focused on promoting consistency and quantification in terminology and methods to aid in the conduct, analysis and interpretation of scientific studies of medication adherence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of the paper selection process
Figure 2
Figure 2
Frequency histogram presenting the evolution over time of the main terms used among the 146 papers to describe deviations from prescribed treatments. Adherence (formula image); Compliance (formula image); Persistence (formula image); Concordance (formula image); Pharmionics (formula image); Therapeutic Alliance (formula image); Persistency (formula image); Patient irregularity (formula image); Pharmacoadherence (formula image); Other (formula image)
Figure 3
Figure 3
Time-line of changes in terminology for deviations from prescribed dosing regimens
Figure 4
Figure 4
Illustration of the process of adherence to medication (light blue) and the process of management of adherence (dark blue)
Figure 5
Figure 5
Examples of electronically compiled drug dosing history data in three patients for whom a twice daily dosing regimen was prescribed. Blue dots indicate the dates and times of drug intake. Grey bars indicate missed doses. (A) Patient with late initiation but good implementation. (B) Patient with suboptimal implementation (missed single and consecutive doses, large variability in timing of drug intakes). (C) Patient with excellent implementation but short persistence (early discontinuation)

Comment in

References

    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97. - PubMed
    1. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol. 1993;72:68D–74D. - PubMed
    1. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO; 2003.
    1. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009;59:56–66. - PubMed
    1. Wu JR, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am. 2008;43:133–53. - PubMed

Publication types

MeSH terms

Substances